Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
567 studies found for:    Open Studies | "Pancreatic Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Dietary Supplement: T-ChOS;   Drug: Gemcitabine;   Dietary Supplement: Placebo;   Drug: Capecitabine
22 Recruiting Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
23 Recruiting IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Radiation: Concurrent chemoradiotherapy(CCRT);   Radiation: Stereotactic Radiotherapy(SBRT);   Drug: S-1
24 Not yet recruiting Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
Condition: Pancreatic Cancer
Intervention:
25 Recruiting Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: NK cells;   Procedure: irreversible electroporation (IRE )
26 Recruiting Tumor Registry Pancreatic Cancer
Condition: Pancreas Cancer
Intervention:
27 Recruiting Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: Theragene®,Ad5-yCD/mutTKSR39rep-ADP
28 Recruiting Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours
Condition: Pancreatic Cancer
Intervention: Drug: Oxaliplatin, irinotecan, 5-FU & leucovorin
29 Recruiting IORT Versus CCRT for Pancreatic Cancer
Condition: Pancreatic Cancer Stage IV
Interventions: Radiation: Intraoperative radiotherapy (IORT);   Drug: Sequential chemotherapy;   Radiation: Three dimensional conformal radiation therapy (3D-CRT);   Drug: Concurrent chemotherapy
30 Recruiting The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
Condition: Pancreatic Cancer
Interventions: Drug: Gadobutrol;   Drug: [F-18]HX4;   Drug: Gemcitabine;   Radiation: Radiotherapy;   Procedure: Pancreaticoduodenectomy
31 Recruiting A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Minnelide
32 Recruiting ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: ABT-888 and mFOLFOX-6
33 Recruiting Developing Prehabilitation Program in Patients With Operable Pancreatic Cancer Perioperatively and Following Surgery
Condition: Pancreatic Cancer
Intervention: Behavioral: Physical and nutrition program
34 Recruiting Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.
Condition: Pancreatic Cancer
Interventions: Device: Back-loaded Needle (Device);   Device: Preloaded Needle (Device)
35 Recruiting Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: G-FLIP;   Drug: G-FLIP-DM;   Dietary Supplement: Vitamin C
36 Recruiting Olaparib for BRCAness Phenotype in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Olaparib
37 Recruiting Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy
Condition: Pancreatic Cancer
Interventions: Drug: Induction chemotherapy with gemcitabine or FOLFIRINOX;   Radiation: Radiotherapy, 28 x 1.8 Gy;   Drug: Chemotherapy, gemcitabine;   Drug: Chemotherapy with gemcitabine or FOLFIRINOX according to induction chemotherapy
38 Recruiting BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: FOLFOXA
39 Not yet recruiting Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer
Condition: Unresectable Pancreatic Cancer
Interventions: Drug: Nimotuzumab plus S1;   Drug: Placebo plus S1
40 Recruiting Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail
Condition: Pancreatic Cancer
Interventions: Procedure: Celiac plexus resection;   Procedure: Pancreatectomy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.